Enhanced neointima formation following arterial injury in immune deficient rag-1-/- mice is attenuated by adoptive transfer of CD8+ T cells

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Dimayuga, Paul C ^a   Chyu, Kuang Yuh ^a   Kirzner, Jonathan ^a   Yano, Juliana ^a   Zhao, Xiaoning ^a   Zhou, Jianchang ^a   Shah, Prediman K ^a   Cercek, Bojan ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; HERMES ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; RAG1 PROTEIN; HOMEODOMAIN PROTEIN; RAG 1 PROTEIN; RAG-1 PROTEIN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL WALL THICKENING; ARTERY INJURY; ARTICLE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL SELECTION; CELL SPECIFICITY; CELL TYPE; CONTROLLED STUDY; IMMUNE DEFICIENCY; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTE TRANSFER; MOUSE; NEOINTIMA; NONHUMAN; SMOOTH MUSCLE FIBER; T LYMPHOCYTE ACTIVATION; ANIMAL; CAROTID ARTERY; CD4+ T LYMPHOCYTE; FLOW CYTOMETRY; GENETICS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; IN VITRO STUDY; MALE; METABOLISM; MOUSE MUTANT; PATHOLOGY;

MUS;

ADOPTIVE TRANSFER; ANIMALS; CAROTID ARTERIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; HOMEODOMAIN PROTEINS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, MUTANT STRAINS; NEOINTIMA;

EID: 79956337421     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020214     Document Type: Article

References (41)

1. Tanaka T, Soejima H, Hirai N, Sakamoto T, Yoshimura M, et al. (2004) Comparison of frequency of interferon-gamma-positive CD4+ T cells before and after percutaneous coronary intervention and the effect of statin therapy in patients with stable angina pectoris. Am J Cardiol 93: 1547-1549.
2. Brunetti ND, Pepe M, Munno I, Tiecco F, Quagliara D, et al. (2008) Th2-dependent cytokine release in patients treated with coronary angioplasty. Coron Artery Dis 19: 133-137.
3. Sardella G, Accapezzato D, Di RA, Francavilla V, Di RC, et al. (2005) Altered trafficking of CD8+ memory T cells after implantation of rapamycin-eluting stents in patients with coronary artery disease. Immunol Lett 96: 85-91.
4. Nakazawa G, Finn AV, Virmani R, (2007) Vascular pathology of drug-eluting stents. Herz 32: 274-280.
5. Steffel J, Tanner FC, (2007) Biological effects of drug-eluting stents in the coronary circulation. Herz 32: 268-273.
6. Dimayuga PC, Chyu KY, Cercek B, (2010) Immune responses regulating the response to vascular injury. Curr Opin Lipidol 21: 416-421.
7. Navarro-Lopez F, Francino A, Serra A, Enjuto M, Reverter JC, et al. (2003) [Late T-lymphocyte and monocyte activation in coronary restenosis. Evidence for a persistent inflammatory/immune mechanism?]. Rev Esp Cardiol 56: 465-472.
8. Shi Y, Zheng W, Rock KL, (2000) Cell injury releases endogenous adjuvants that stimulate cytotoxic T cell responses. Proc Natl Acad Sci U S A 97: 14590-14595.
9. Wallin RP, Lundqvist A, More SH, von BA, Kiessling R, et al. (2002) Heat-shock proteins as activators of the innate immune system. Trends Immunol 23: 130-135.
10. Strom A, Wigren M, Hultgardh-Nilsson A, Saxena A, Gomez MF, et al. (2007) Involvement of the CD1d-natural killer T cell pathway in neointima formation after vascular injury. Circ Res 101: e83-e89.
11. Zernecke A, Liehn EA, Gao JL, Kuziel WA, Murphy PM, et al. (2006) Deficiency in CCR5 but not CCR1 protects against neointima formation in atherosclerosis-prone mice: involvement of IL-10. Blood 107: 4240-4243.
12. Kovacic JC, Gupta R, Lee AC, Ma M, Fang F, et al. (2010) Stat3-dependent acute Rantes production in vascular smooth muscle cells modulates inflammation following arterial injury in mice. J Clin Invest 120: 303-314.
13. Kurobe H, Urata M, Ueno M, Ueki M, Ono S, et al. (2010) Role of hypoxia-inducible factor 1alpha in T cells as a negative regulator in development of vascular remodeling. Arterioscler Thromb Vasc Biol 30: 210-217.
14. Hansson GK, Holm J, Holm S, Fotev Z, Hedrich HJ, et al. (1991) T lymphocytes inhibit the vascular response to injury. Proc Natl Acad Sci U S A 88: 10530-10534.
15. Dimayuga P, Cercek B, Oguchi S, Fredrikson GN, Yano J, et al. (2002) Inhibitory effect on arterial injury-induced neointimal formation by adoptive B-cell transfer in Rag-1 knockout mice. Arterioscler Thromb Vasc Biol 22: 644-649.
16. Dimayuga PC, Li H, Chyu KY, Fredrikson GN, Nilsson J, et al. (2005) T cell modulation of intimal thickening after vascular injury: the bimodal role of IFN-gamma in immune deficiency. Arterioscler Thromb Vasc Biol 25: 2528-2534.
17. Zhu B, Reardon CA, Getz GS, Hui DY, (2002) Both apolipoprotein E and immune deficiency exacerbate neointimal hyperplasia after vascular injury in mice. Arterioscler Thromb Vasc Biol Mar 22: 450-455.
18. Remskar M, Li H, Chyu KY, Shah PK, Cercek B, (2001) Absence of CD40 signaling is associated with an increase in intimal thickening after arterial injury. Circ Res 88: 390-394.
19. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, et al. (1992) RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68: 869-877.
20. Dimayuga PC, Cesena FH, Chyu KY, Yano J, Amorn A, et al. (2009) Natural antibodies and complement modulate intimal thickening after arterial injury. Am J Physiol Regul Integr Comp Physiol 297: R1593-R1600.
21. Turka LA, Ledbetter JA, Lee K, June CH, Thompson CB, (1990) CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature thymocytes. J Immunol 144: 1646-1653.
22. Malek TR, (2003) The main function of IL-2 is to promote the development of T regulatory cells. J Leukoc Biol 74: 961-965.
23. DeGrendele HC, Estess P, Siegelman MH, (1997) Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science 278: 672-675.
24. Kieper WC, Jameson SC, (1999) Homeostatic expansion and phenotypic conversion of naive T cells in response to self peptide/MHC ligands. Proc Natl Acad Sci U S A 96: 13306-13311.
25. Goldrath AW, Bogatzki LY, Bevan MJ, (2000) Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. J Exp Med 192: 557-564.
26. Tyznik AJ, Sun JC, Bevan MJ, (2004) The CD8 population in CD4-deficient mice is heavily contaminated with MHC class II-restricted T cells. J Exp Med 199: 559-565.
27. Peng Y, Martin DA, Kenkel J, Zhang K, Ogden CA, et al. (2007) Innate and adaptive immune response to apoptotic cells. J Autoimmun 29: 303-309.
28. Zhou X, Nicoletti A, Elhage R, Hansson GK, (2000) Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation 102: 2919-2922.
29. Hancock WW, Adams DH, Wyner LR, Sayegh MH, Karnovsky MJ, (1994) CD4+ mononuclear cells induce cytokine expression, vascular smooth muscle cell proliferation, and arterial occlusion after endothelial injury. Am J Pathol 145: 1008-1014.
30. Hart MN, Tassell SK, Sadewasser KL, Schelper RL, Moore SA, (1985) Autoimmune vasculitis resulting from in vitro immunization of lymphocytes to smooth muscle. Am J Pathol 119: 448-455.
31. Wang GL, Semenza GL, (1993) General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci U S A 90: 4304-4308.
32. Richard DE, Berra E, Pouyssegur J, (2000) Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J Biol Chem 275: 26765-26771.
33. Karshovska E, Zernecke A, Sevilmis G, Millet A, Hristov M, et al. (2007) Expression of HIF-1alpha in injured arteries controls SDF-1alpha mediated neointima formation in apolipoprotein E deficient mice. Arterioscler Thromb Vasc Biol 27: 2540-2547.
34. Lukashev D, Caldwell C, Ohta A, Chen P, Sitkovsky M, (2001) Differential regulation of two alternatively spliced isoforms of hypoxia-inducible factor-1 alpha in activated T lymphocytes. J Biol Chem 276: 48754-48763.
35. Lukashev D, Klebanov B, Kojima H, Grinberg A, Ohta A, et al. (2006) Cutting edge: hypoxia-inducible factor 1alpha and its activation-inducible short isoform I.1 negatively regulate functions of CD4+ and CD8+ T lymphocytes. J Immunol 177: 4962-4965.
36. Eltzschig HK, Carmeliet P, (2011) Hypoxia and inflammation. N Engl J Med 364: 656-665.
37. Kuhlicke J, Frick JS, Morote-Garcia JC, Rosenberger P, Eltzschig HK, (2007) Hypoxia inducible factor (HIF)-1 coordinates induction of Toll-like receptors TLR2 and TLR6 during hypoxia. PLoS One 2: e1364.
38. Schoneveld AH, Oude Nijhuis MM, van MB, Laman JD, de Kleijn DP, et al. (2005) Toll-like receptor 2 stimulation induces intimal hyperplasia and atherosclerotic lesion development. Cardiovasc Res 66: 162-169.
39. Shishido T, Nozaki N, Takahashi H, Arimoto T, Niizeki T, et al. (2006) Central role of endogenous Toll-like receptor-2 activation in regulating inflammation, reactive oxygen species production, and subsequent neointimal formation after vascular injury. Biochem Biophys Res Commun 345: 1446-1453.
40. Chyu KY, Dimayuga P, Zhu J, Nilsson J, Kaul S, et al. (1999) Decreased neointimal thickening after arterial wall injury in inducible nitric oxide synthase knockout mice. Circ Res 85: 1192-1198.
41. Lecoeur H, Fevrier M, Garcia S, Riviere Y, Gougeon ML, (2001) A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity. J Immunol Methods 253: 177-187.